NIHR Doctoral Research Fellow
I am an NIHR Doctoral Research Fellow in the Health Economics Research Centre at NDPH. My DPhil aims to provide economic evidence regarding the role of precision medicine in prediabetes.
Prediabetes affects people in different ways, with some developing type 2 diabetes very quickly and some not at all. Nevertheless, prediabetes screening and treatment is generally the same for all patients, as the economic argument for precision medicine in prediabetes is not established.
In my DPhil, I am building and validating a new economic model of prediabetes and its consequences. This combines data from several clinical trials and cohort studies to predict individual patients’ long-term health outcomes and costs. This will allow us to understand the cost-effectiveness of early precision interventions targeted to specific prediabetes patients.
I joined HERC in 2019 as a researcher in health economics, and prior to this I held a NIHR Research Methods Fellowship at the Centre for Health Economics at the University of York. At York, I was a member of a NICE academic evidence review group critiquing the economic case for introducing new pharmaceuticals and medical devices into the NHS.
I hold an MSc in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine, and a BA in Philosophy, Politics and Economics from the University of Oxford.
Cost-effectiveness of point-of-care creatinine testing to assess kidney function prior to contrast-enhanced computed tomography imaging.
Duarte A. et al, (2021), Eur J Radiol, 142
Appraisal of patient-level health economic models of severe mental illness: systematic review
Altunkaya J. et al, (2021), The British Journal of Psychiatry, 1 - 12
Cost-effectiveness of amphotericin B deoxycholate versus itraconazole for induction therapy of talaromycosis in HIV-infected adults in Vietnam
BUCHANAN J. et al, (2021), Open Forum Infectious Diseases
Program Evaluation of Population- and System-Level Policies: Evidence for Decision Making.
Walker S. et al, (2021), Med Decis Making
Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
Corbett M. et al, (2020), Health Technol Assess, 24, 1 - 248